B
Bailard Portfolio holdings
AUM
$4.29B
1-Year Return
18.39%
This Quarter Return
-12.09%
1 Year Return
+18.39%
3 Year Return
+76.25%
5 Year Return
+133.74%
10 Year Return
+353.73%
AUM
$2.54B
AUM Growth
-$433M
(-15%)
Cap. Flow
-$8.39M
Cap. Flow
% of AUM
-0.33%
Top 10 Holdings %
Top 10 Hldgs %
31.88%
Holding
847
New
132
Increased
213
Reduced
233
Closed
169
Top Buys
Top Sells
| 1 |
SPDR Gold Trust
GLD
|
$73.6M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$67.9M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
$57.9M |
| 4 |
iShares California Muni Bond ETF
CMF
|
$18.7M |
| 5 |
iShares US Real Estate ETF
IYR
|
$9.87M |
Sector Composition
| 1 | Technology | 17.33% |
| 2 | Healthcare | 8.9% |
| 3 | Financials | 6.63% |
| 4 | Consumer Staples | 4.48% |
| 5 | Communication Services | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Nomura Holdings
NMR
$21.1B
| $163K | 0.01% |
45,534
+5,103
| +13% | +$18.3K |
|
627
Natural Gas Services Group
NGS
$332M
| $161K | 0.01% |
+14,596
| New | +$161K |
|
628
Designer Brands
DBI
$231M
| $158K | 0.01% |
+12,100
| New | +$158K |
|
|
ESTE
629
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $158K | 0.01% |
11,600
-9,600
| -45% | -$131K |
|
630
Ironwood Pharmaceuticals
IRWD
$188M
| $156K | 0.01% |
+13,500
| New | +$156K |
|
|
TCS
631
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $155K | 0.01% |
+1,660
| New | +$155K |
|
632
Puma Biotechnology
PBYI
$253M
| $152K | 0.01% |
+53,500
| New | +$152K |
|
633
SIGA Technologies
SIGA
$603M
| $152K | 0.01% |
+13,100
| New | +$152K |
|
634
E.W. Scripps
SSP
$261M
| $150K | 0.01% |
+12,000
| New | +$150K |
|
|
CTG
635
DELISTED
Computer Task Group, Inc.
CTG
| $146K | 0.01% |
+17,084
| New | +$146K |
|
636
Banco Bilbao Vizcaya Argentaria
BBVA
$105B
| $144K | 0.01% |
31,921
+997
| +3% | +$4.5K |
|
637
Black Diamond Therapeutics
BDTX
$167M
| $144K | 0.01% |
+58,500
| New | +$144K |
|
|
CMRX
638
DELISTED
Chimerix, Inc.
CMRX
| $142K | 0.01% |
+68,100
| New | +$142K |
|
639
Amneal Pharmaceuticals
AMRX
$3.02B
| $141K | 0.01% |
+44,200
| New | +$141K |
|
640
The RealReal
REAL
$999M
| $137K | 0.01% |
+55,137
| New | +$137K |
|
641
Organogenesis Holdings
ORGO
$634M
| $136K | 0.01% |
+27,900
| New | +$136K |
|
642
Crown Crafts
CRWS
$32.1M
| $134K | 0.01% |
+21,469
| New | +$134K |
|
643
Caribou Biosciences
CRBU
$174M
| $128K | 0.01% |
+23,500
| New | +$128K |
|
644
ALX Oncology
ALXO
$65.3M
| $125K | ﹤0.01% |
+15,510
| New | +$125K |
|
|
UNIT
645
Uniti Group
UNIT
$1.59B
| $125K | ﹤0.01% |
13,287
| – | – |
|
646
Harrow
HROW
$1.37B
| $123K | ﹤0.01% |
16,837
+1,515
| +10% | +$11.1K |
|
647
Rhythm Pharmaceuticals
RYTM
$6.78B
| $122K | ﹤0.01% |
+29,500
| New | +$122K |
|
648
Annexon
ANNX
$238M
| $110K | ﹤0.01% |
+29,086
| New | +$110K |
|
649
Xilio Therapeutics
XLO
$36.3M
| $107K | ﹤0.01% |
+36,632
| New | +$107K |
|
650
Capricor Therapeutics
CAPR
$308M
| $104K | ﹤0.01% |
+29,801
| New | +$104K |
|